Minerva Neurosciences Inc. completed its initial public offering of nearly 5.5 million shares, which began trading on 1 July 2014 on the NASDAQ Global Market under the ticker symbol «NERV». Prior to the IPO, Minerva acquired all shares in Mind-NRG S.A., a Swiss pre-clinical stage pharmaceutical company.

News

5 August 2014

Minerva IPO and Acquisition

Minerva Neurosciences Inc. completed its initial public offering of nearly 5.5 million shares, which began trading on 1 July 2014 on the NASDAQ Global Market under the ticker symbol «NERV». Prior to the IPO, Minerva acquired all shares in Mind-NRG S.A., a Swiss pre-clinical stage pharmaceutical company.